Item
Vitamin B6 Pyridoxine HCL DC 98% (P1277-00)
Huazhong Pharmacetucial Co., Ltd
96.0%~99.0% Pyridoxine HCL DC
2.0% HPMC
Nutrient / Vitamin
Attributes
- Ingredient declaration
Applications
- Dietary Supplements/Nutraceuticals
Functions
- Active Ingredient
Features & benefits
- Vegetarian
Tags
- Halal
- Kosher
- Non-GMO
- Vegan
Locations
Location name | Address |
---|---|
H&M USA INC. | 80 Gordon Drive Syosset, NY 11791 |
H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | No.118 XIANSHAN RD Xiangyang, HB 441023 CHN |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
Product Specification Sheet | H&M USA INC. | 8. specification (2)_Vitamin B6 Pyridoxine HCL DC 98%_Hebei Huazhong.pdf | 5/3/2024 | 5/3/2027 |
Allergens | H&M USA INC. | Allergens.pdf | 4/14/2025 | 4/14/2027 |
Allergens | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | Allergens.pdf | 4/14/2025 | 4/14/2027 |
CoA Sample | H&M USA INC. | B6 Pyridoxine HCL DC 98%-Hubei Huazhong Lot# K03202110024.pdf | 3/24/2025 | 3/24/2027 |
Country of Origin | H&M USA INC. | Country of Origin.pdf | 4/14/2025 | 4/13/2028 |
Country of Origin | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | Country of Origin.pdf | 4/14/2025 | 4/13/2028 |
Dietary Supplement Questionnaire | H&M USA INC. | Dietary Supplement Questionnaire.pdf | 4/14/2025 | 4/14/2026 |
Dietary Supplement Questionnaire | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | Dietary Supplement Questionnaire.pdf | 4/14/2025 | 4/14/2026 |
HARPC Food Safety Plan (Item) | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | Food Safety Plan_Huazhong_EN.pdf | 4/2/2024 | 4/2/2027 |
HACCP | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | HACCP Plan VB6 Pyridoxine Hydrochloride DC_Huazhong.pdf | 3/27/2024 | 3/27/2027 |
Kosher | H&M USA INC. | Kosher Cert_Huazhong Pharm_043026.pdf | 3/28/2025 | 4/30/2026 |
Nutrition | H&M USA INC. | Nutrition.pdf | 4/14/2025 | 4/13/2028 |
Nutrition | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | Nutrition.pdf | 4/14/2025 | 4/13/2028 |
Animal Testing Statement | H&M USA INC. | P1277-00 - Animal Testing.pdf | 4/14/2025 | 4/14/2027 |
Animal Testing Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Animal Testing.pdf | 4/14/2025 | 4/14/2027 |
BSE - TSE | H&M USA INC. | P1277-00 - BSE-TSE.pdf | 4/14/2025 | 4/13/2028 |
BSE - TSE | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - BSE-TSE.pdf | 4/14/2025 | 4/13/2028 |
Ingredient Statement | H&M USA INC. | P1277-00 - Composition.pdf | 4/14/2025 | 4/13/2028 |
Ingredient Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Composition.pdf | 4/14/2025 | 4/13/2028 |
EtO Statement | H&M USA INC. | P1277-00 - EtO & Irradiation.pdf | 4/14/2025 | 4/14/2027 |
EtO Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - EtO & Irradiation.pdf | 4/14/2025 | 4/14/2027 |
Irradiation Status Statement | H&M USA INC. | P1277-00 - EtO & Irradiation.pdf | 4/14/2025 | 4/14/2027 |
Irradiation Status Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - EtO & Irradiation.pdf | 4/14/2025 | 4/14/2027 |
HACCP Process Flow Diagram | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Flow Chart.pdf | 4/14/2025 | 4/14/2027 |
HACCP Process Flow Diagram | H&M USA INC. | P1277-00 - Flow Chart.pdf | 4/14/2025 | 4/14/2027 |
Gluten | H&M USA INC. | P1277-00 - Gluten.pdf | 4/14/2025 | 4/14/2027 |
Gluten | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Gluten.pdf | 4/14/2025 | 4/14/2027 |
GMO | H&M USA INC. | P1277-00 - GMO.pdf | 4/14/2025 | 4/14/2027 |
GMO | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - GMO.pdf | 4/14/2025 | 4/14/2027 |
GRAS/NDI/ODI Statement | H&M USA INC. | P1277-00 - GRAS.pdf | 4/14/2025 | 4/13/2028 |
GRAS/NDI/ODI Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - GRAS.pdf | 4/14/2025 | 4/13/2028 |
Halal | H&M USA INC. | P1277-00 - Halal.pdf | 4/1/2025 | 3/31/2027 |
Heavy Metal | H&M USA INC. | P1277-00 - Heavy Metals.pdf | 4/14/2025 | 4/14/2027 |
Heavy Metal | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Heavy Metals.pdf | 4/14/2025 | 4/14/2027 |
Mycotoxin Statement | H&M USA INC. | P1277-00 - Mycotoxins.pdf | 1/8/2025 | 1/8/2027 |
Mycotoxin Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Mycotoxins.pdf | 1/8/2025 | 1/8/2027 |
Pesticide | H&M USA INC. | P1277-00 - Pesticides.pdf | 4/14/2025 | 4/14/2027 |
Pesticide | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Pesticides.pdf | 4/14/2025 | 4/14/2027 |
California Prop. 65 | H&M USA INC. | P1277-00 - Prop 65.pdf | 4/14/2025 | 4/14/2027 |
California Prop. 65 | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Prop 65.pdf | 4/14/2025 | 4/14/2027 |
Residual Statement | H&M USA INC. | P1277-00 - Residual Solvents.pdf | 4/14/2025 | 4/14/2026 |
Residual Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Residual Solvents.pdf | 4/14/2025 | 4/14/2026 |
CoA Sample | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Sample CoA.pdf | 4/10/2025 | 4/10/2027 |
Safety Data Sheet (SDS) | H&M USA INC. | P1277-00 - SDS.pdf | 4/14/2025 | 4/13/2028 |
Safety Data Sheet (SDS) | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - SDS.pdf | 4/14/2025 | 4/13/2028 |
Sewage Statement | H&M USA INC. | P1277-00 - Sewage Sludge.pdf | 4/14/2025 | 4/14/2027 |
Sewage Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Sewage Sludge.pdf | 4/14/2025 | 4/14/2027 |
Vegan/Vegetarian Statement | H&M USA INC. | P1277-00 - Vegan.pdf | 4/14/2025 | 4/14/2027 |
Vegan/Vegetarian Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - Vegan.pdf | 4/14/2025 | 4/14/2027 |
WADA/NSF/NFL Statement | H&M USA INC. | P1277-00 - WADA.pdf | 4/14/2025 | 4/14/2027 |
WADA/NSF/NFL Statement | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | P1277-00 - WADA.pdf | 4/14/2025 | 4/14/2027 |
Suitability Requirements | H&M USA INC. | Suitability Requirements.pdf | 4/14/2025 | 4/13/2028 |
Suitability Requirements | H&M USA INC. - Huazhong Pharmaceutical, Co. Ltd. | Suitability Requirements.pdf | 4/14/2025 | 4/13/2028 |